Biota Reports Positive Phase IIb Data For Asthmatic Patients With HRV Infection – NASDAQ

Biota Reports Positive Phase IIb Data For Asthmatic Patients With HRV Infection
NASDAQ
The Phase II multicenter, randomized, double-blind, placebo controlled study in asthmatic adults with symptomatic, naturally acquired human rhinovirus infection was conducted over two consecutive seasons in 48 centers in the US Subjects received either
Biota Announces Positive Phase IIb Data for Asthmatic Patients With Human MarketWatch (press release)

all 6 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.